Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Uterine Cervical Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Pleural Effusion, Malignant 1Oropharyngeal Neoplasms 1Nose Neoplasms 1Neoplasm Metastasis 1Esthesioneuroblastoma, Olfactory 1Anus Neoplasms 1

Interventions

Trastuzumab 2Docetaxel 2Carboplatin 2Bortezomib 2tipifarnib 1saracatinib 1Taxes 1Pleurodesis 1Paclitaxel 1Morphine 1LMB-100 1Interleukin-12 Subunit p35 1Interleukin-12 1Ibuprofen 1Gemcitabine 1Erlotinib Hydrochloride 1Decitabine 1Cytoreduction Surgical Procedures 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Pleural Effusion, Malignant × Ibuprofen × Clear all
NCT00644319 2009-07-08

Ibuprofen or Morphine in Treating Pain in Patients Undergoing Pleurodesis for Malignant Pleural Effusion

National Cancer Institute (NCI)

Phase 2 Unknown
320 enrolled
Thoracic

Neoplasm Metastasis, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡